Regeneron, Sanofi slash Praluent list price mirroring Repatha discount
Following Amgen’s decision to slash the price of its cholesterol drug Repatha by 60% to $5,850 last year, the team behind their main rival …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
